Angiopoietin-1, angiopoietin-2 and Tie-2 in the coronary circulation of patients with and without coronary collateral vessels

Circulation Journal

Volumn 71, Issue 3, 2007, Pages 343-347

  Mitsuma, Wataru ^a   Kodama, Makoto ^a   Hirono, Satoru ^a   Ito, Masahiro ^a   Ramadan, Mahmoud M ^a   Tanaka, Komei ^a   Hoyano, Makoto ^a   Saigawa, Takashi ^a   Kashimura, Takeshi ^a   Fuse, Koichi ^a   Okura, Yuji ^a   Aizawa, Yoshifusa ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Angiopoietin Tie 2 system; Coronary artery disease; Coronary circulation; Coronary collaterals

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY SINUS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART CATHETERIZATION; HEART LEFT VENTRICLE; HUMAN; MAJOR CLINICAL STUDY; MALE;

AGED; ANGIOPOIETIN-1; ANGIOPOIETIN-2; COLLATERAL CIRCULATION; CORONARY ARTERIOSCLEROSIS; CORONARY CIRCULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART CATHETERIZATION; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR, TIE-2; RISK FACTORS;

EID: 33947124477     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.343     Document Type: Article

References (25)

1. Schaper W, Ito WD. Molecular mechanisms of coronary collateral vessel growth. Circ Res 1996; 79: 911-919.
2. Wolf C, Cai WJ, Vosschulte R, Koltai S, Mousavipour D, Scholz D, et al. Vascular remodeling and altered protein expression during growth of coronary collateral arteries. J Mol Cell Cardiol 1998; 30: 2291-2305.
3. Pepper MS. Manipulating angiogenesis: From basic science to the bedside. Arterioscler Thromb Vasc Biol 1997; 17: 605-619.
4. Toyota E, Matsunaga T, Chilian WM. Myocardial angiogenesis. Mol Cell Biochem 2004; 264: 35-44.
5. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000; 407: 242-248.
6. Lambiase PD, Edwards RJ, Anthopoulos P, Rahman S, Meng YG, Bucknall CA, et al. Circulating humoral factors and endothelial progenitor cells in patients with differing coronary collateral support. Circulation 2004; 109: 2986-2992.
7. Fleisch M, Billinger M, Eberli FR, Garachemani AR, Meier B, Seiler C. Physiologically assessed coronary collateral flow and intracoronary growth factor concentrations in patients with 1- to 3-vessel coronary artery disease. Circulation 1999; 100: 1945-1950.
8. Werner GS, Jandt E, Krack A, Schwarz G, Mutschke O, Kuethe F, et al. Growth factors in the collateral circulation of chronic total coronary occlusions: Relation to duration of occlusion and collateral function. Circulation 2004; 110: 1940-1945.
9. Sato TN, Qin Y, Kozak CA, Audus KL. Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. Proc Natl Acad Sci USA 1993; 90: 9355-9358.
10. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 1996; 87: 1161-1169.
11. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277: 55-60.
12. Lee KW, Lip GY, Blann AD. Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes. Circulation 2004; 110: 2355-2360.
13. Chung NA, Makin AJ, Lip GY. Measurement of the soluble angiopoietin receptor tie-2 in patients with coronary artery disease: Development and application of an immunoassay. Eur J Clin Invest 2003; 33: 529-535.
14. Shyu KG, Chang CC, Wang BW, Kuan P, Chang H. Increased expression of angiopoietin-2 and Tie2 receptor in a rat model of myocardial ischaemia/reperfusion. Clin Sci (Lond) 2003; 105: 287-294.
15. Sandhu R, Teichert-Kuliszewska K, Nag S, Proteau G, Robb MJ, Campbell AI, et al. Reciprocal regulation of angiopoietin-1 and angiopoietin-2 following myocardial infarction in the rat. Cardiovasc Res 2004; 64: 115-124.
16. Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: Implications for patient selection (Multivessel Angioplasty Prognosis Study Group). Circulation 1990; 82: 1193-1202.
17. Cohen M, Rentrop KP. Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: A prospective study. Circulation 1986; 74: 469-476.
18. Ramadan MM, Kodama M, Mitsuma W, Ito M, Kashimura T, Ikrar T, et al. Impact of percutaneous coronary intervention on the levels of interleukin-6 and C-reactive protein in the coronary circulation of subjects with coronary artery disease. Am J Cardiol 2006; 98: 915-917.
19. Mandriota SJ, Pepper MS. Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ Res 1998; 83: 852-859.
20. Oh H, Takagi H, Suzuma K, Otani A, Matsumura M, Honda Y. Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J Biol Chem 1999; 274: 15732-15739.
21. Reusch P, Barleon B, Weindel K, Martiny-Baron G, Godde A, Siemeister G, et al. Identification of a soluble form of the angiopoietin receptor TIE-2 released from endothelial cells and present in human blood. Angiogenesis 2001; 4: 123-131.
22. Willam C, Koehne P, Jurgensen JS, Grafe M, Wagner KD, Bachmann S, et al. Tie2 receptor expression is stimulated by hypoxia and proinflammatory cytokines in human endothelial cells. Circ Res 2000; 87: 370-377.
23. Lin P, Polverini P, Dewhirst M, Shan S, Rao PS, Peters K. Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth. J Clin Invest 1997; 100: 2072-2078.
24. Lobov IB, Brooks PC, Lang RA. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci USA 2002; 99: 11205-11210.
25. Asahara T, Chen D, Takahashi T, Fujikawa K, Kearney M, Magner M, et al. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res 1998; 83: 233-240.